Researchers at UT Southwestern Medical Center and in Australia have shown that a drug currently in testing shows potential to cure malaria in a single dose and offers promise as a preventive treatment as well.
The new drug – DSM265 kills drug-resistant malaria parasites in the blood and liver by targeting their ability to replicate. Malaria is a highly infectious, mosquito-transmitted disease that kills nearly 600,000 people worldwide each year, mostly children under 5 years old living in sub-Saharan Africa. Nearly 200 million cases of malaria are reported annually, and about 3 billion people are at risk of malaria in 97 countries.
“DSM265 could be among the first single-dose cures for malaria, and would be used in partnership with another drug,” said lead author Dr. Margaret Phillips, Professor of Pharmacology at UT Southwestern. “The drug also could potentially be developed as a once-weekly preventive.”
The research team included UT Southwestern, the Monash Institute of Pharmaceutical Sciences in Australia, the University of Washington, and the not-for-profit Medicines for Malaria Venture (MMV). The study was published inScience Translational Medicine.
Researchers determined that the compound DSM265 kills the malaria parasite Plasmodium in both liver and blood stages of infection. Further, the compound was shown to be well tolerated and effective in preclinical models.
Currently, the frontline anti-malarial treatments are artemisinin-based combination therapies, or ACTs, which are credited with helping to reduce the malaria burden. However, malaria strains resistant to ACTs have recently been reported in Thailand, Cambodia, Vietnam, Myanmar, and Laos.
“The problem is we’re starting to see more drug resistance, and this is what’s taken out every anti-malarial drug we’ve had,” said Dr. Phillips, who holds the Beatrice and Miguel Elias Distinguished Chair in Biomedical Science, and the Carolyn R. Bacon Professorship in Medical Science and Education. “The parasite is very good at adapting and becoming resistant to drugs ? this is inevitable. What we can do is deliver new medicines with new modes of action and safeguard the longevity of the anti-malarial through use in combination as long as possible.”
In order to combat drug resistance, DSM265 likely would be partnered with another new drug and used as a one-dose combination therapy. Another option is to develop DSM265 as a once-weekly preventive for individuals traveling to malaria-endemic regions or for people living in areas where malaria infections are primarily seasonal and human immunity is low. Either scenario is still several years away, pending the outcome of current and future trials, said Dr. Phillips.
DSM265 targets the ability of the parasite to synthesize the nucleotide precursors required for synthesis of DNA and RNA, said Dr. Phillips.
The study concluded that DSM265 appeared to be safely tolerated in non-human tests and established optimal dosing levels and length of drug effectiveness in preclinical models to estimate dosing for humans, paving the way for clinical trials. The first clinical trial was a safety study in Australia, followed by an ongoing efficacy study in Peru to evaluate the ability to treat patients with malaria. Additional human studies are planned, including one to test the drug as a preventive medicine. UT Southwestern is assisting in an advisory capacity in these studies and is providing support with biomarker assays.
The Latest on: Malaria
via Google News
The Latest on: Malaria
- 3 years after constable died of malaria, FIR on 2 JJ doctorson January 22, 2021 at 2:34 pm
It took three years for the police to conclude that constable Gorakshak Narsale who was infected with malaria died within three days of admiss.
- Outlook on the Malaria Vaccines Global Market to 2021-2026 Impact Analysis of COVID-19on January 21, 2021 at 7:47 pm
Selbyville, Delaware, Global Malaria Vaccines Market Report added at Market Study Report LLC offers industry size, share, growth, trends and forecast analysis up to 2026. 'Malaria Vaccines Market Size ...
- South African Scientists Make ‘Breakthrough’ in Killing Malaria Before It’s Infectiouson January 21, 2021 at 3:25 am
South African scientists have identified a new chemical compound that has the ability to treat malaria and even kill the malaria parasite before it becomes infectious. The discovery was made by ...
- Newly discovered chemical could be a solution to malariaon January 20, 2021 at 9:03 am
A new chemical has been discovered by a research team which could potentially eliminate malaria. The chemical compound was discovered by researchers at the University of Pretoria (UP). South Africa is ...
- Consider malaria-like symptoms as COVID-19 until proven otherwise — Sanwo-Oluon January 19, 2021 at 1:25 pm
Olu of Lagos State on Tuesday said any malaria-like symptoms should be considered as COVID-19 infection until proven otherwise. Sanwo-Olu said this while addressing Lagos State Government House ...
- Malaria Vaccines Market Size 2020 Analysis and In-depth Research on Trends, Emerging Growth Factors and Forecast to 2024on January 19, 2021 at 2:28 am
Malaria Vaccines Market” forecast 2020-2024 report analyses the current and future competitive scenario of the global Healthcare , Pharmaceuticals industry. Malaria Vaccines ...
- Similar symptoms could see malaria pose more of a threat than Covid-19on January 18, 2021 at 11:15 pm
Malaria may pose a more immediate threat than Covid-19 because some of the symptoms of the two infections are similar, said co-founder of Goodbye Malaria, Sherwin Charles. He said malaria proved to be ...
- How fighting malaria is helping to tackle Covid-19 around the worldon January 18, 2021 at 8:26 pm
ADVERTISER CONTENT FROM COMIC RELIEF AND GSK HOSTED BY THE GUARDIAN | Covid-19 could undo the progress made against malaria – one of the world’s deadliest diseases ...
- 'They use SMS, voicemail and chat apps': how young reporters in Sierra Leone are documenting the impact of malariaon January 18, 2021 at 8:21 pm
ADVERTISER CONTENT FROM COMIC RELIEF AND GSK HOSTED BY THE GUARDIAN | A network of reporters is investigating the impact of malaria and Covid-19 on communities ...
- South African scientists discover new chemicals that kill malaria parasiteon January 15, 2021 at 1:02 pm
South African scientists have discovered chemical compounds that could potentially be used for a new line of drugs to treat malaria and even kill the parasite in its infectious stage, which most ...
via Bing News